Surmodics | SRDX - Ebitda





Ebitda Veränderung Datum
Abbott USD 3.27B 178M 2025-12
Align Technology USD 260.87M 77.03M 2025-12
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD 64.2M 223.53M 2025-09
Artivion USD 22.72M 1.84M 2025-12
Baxter International USD -447M 873M 2025-12
Boston Scientific USD 1.16B 213M 2025-12
EDAP TMS EUR -4.92M 843K 2025-09
Edwards Lifesciences USD 70.1M 394.2M 2025-12
Haemonetics USD 115.53M 9.22M 2025-09
Heron Therapeutics USD -3.88M 5.63M 2024-09
J&J USD 7.19B 2.32B 2025-12
Merit Medical Systems USD 97.23M 17.69M 2025-12
Mesa Laboratories USD 9.58M 1.47M 2024-09
Nektar Therapeutics USD -31.81M 70K 2023-09
Option Care Health USD 104.77M 21.23M 2026-03
Stryker USD 1.57B 618M 2026-03
Surmodics USD 3.43M 1.9M 2025-06
Trinity Biotech USD -9.6M 7.64M 2024-12